Metabolic disturbances in PE encompass impaired lipid and carbohydrate metabolism, insulin resistance, and IGF dysregulation, all contributing to endothelial dysfunction, systemic inflammation, and placental insufficiency. This evidence concerns the gene IGF1 and Insulin resistance.